| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.29 | 0.1 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.26 | 0.4 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.01 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.02 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.17 | 0.6 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.17 | 0.003 |